Standard Corneal Collagen Crosslinking Versus Transepithelial Corneal Crosslinking by Iontophoresis of Riboflavin
Comparative Study of Results of Standard Corneal Collagen Crosslinking Versus Transepithelial Corneal Crosslinking by Iontophoresis of Riboflavin: a Randomized Control Trial
  • Phase

  • Study Type

  • Status

    Completed No Results Posted
  • Intervention/Treatment

    dextralink riboflavin ...
  • Study Participants

The standard CXL technique involves removal of the epithelium to enable riboflavin to penetrate into stromal tissue, to avoid epithelial debridement and increasing the patient's comfort and safety transepithelial corneal crosslinking (CXL) was suggested. Iontophoresis of riboflavin is one of approach for riboflavin impregnation.

In this study, the investigators compared the results of standard corneal crosslinking (CXL) and transepithelial CXL via iontophoresis of riboflavin after 24 months follow up.
Study Started
Jan 31
Primary Completion
Dec 31
Study Completion
Dec 31
Last Update
May 29

Procedure iontophoresis of riboflavin

Procedure epithelium-off

Procedure Corneal collagen crosslinking

Standard surface UVA irradiation (370 nm, 3 mW/cm2; UFalink, Russian Federation) was then applied at a 5-cm distance for 30 minutes. During UVA exposure, hypotonic riboflavin drops were continued every 2 minutes.

Device galvanizator, Potok-1

Device for providing iontophoresis procedure

Drug Dextralink

Riboflavin 0,1% + Dextran T-500

Drug Riboflavin 0,1%

Device UFalink

device for UVA irradiation - providing UVA light - 370 nm, 3 mW/cm2

Standard epithelium-off CXL Active Comparator

Removing the central 8-10mm of the epithelium and applying a riboflavin solution (0.1% riboflavin-5-phosphate and 20% dextran T-500) to the corneal surface 30 minutes before irradiation and at 5 minutes intervals during the course of a 30 minute exposure to 370 nm UVA with an irradiance of 3 mWcm-2 (UFalink, Russian Federation)

Transepithelial CXL via iontophoresis of riboflavin Experimental

impregnation of the cornea with a riboflavin 0.1% hypotonic solution is performed by using an iontophoresis device (galvanizator; Potok-1, Russian Federation). The passive electrode (anode) was applied to the inferior part of the cervical vertebrae. The active electrode (cathode), a bath tube (glass or plastic - 10-12 ml) is applied to the open eye,then r the tube is taped to the skin of the orbital margins and filled with riboflavin 0.1%. The current intensity is initially 0.2 mA and then gradually increased to 1.0 mA at 0.2 mA for 1 minute at 10-second intervals increments to determine individual tolerance. The total time that the riboflavin administration is 10 minutes. Standard surface UVA irradiation (370 nm, 3 mW/cm2) using UFalink device, (Russian Federation) is then applied at a 5-cm distance for 30 minutes with continuing hypotonic riboflavin drops every 2 minutes


Inclusion Criteria:

Documented progressive KC (by Pentacam and/or corneal topography imaging).
A clear central cornea.
A minimal corneal thickness of ≥ 400 µm at the thinnest corneal location (Pentacam imaging).
Minimal Snellen corrected distance visual acuity of ≥ 0.4.
Patient age of ≥ 18 years.

Exclusion Criteria:

Corneal scarring.
History of epithelial healing problems.
History or presence of ocular infection (such as herpes keratitis)
Pregnancy and/or breastfeeding.
No Results Posted